Dangerous Drugs

When a drug is approved and put on the market, patients and their healthcare providers trust the drug is safe.

dangerous drugs

A few mild side effects might be expected, but some drugs can cause serious complications that were not anticipated by the patient or their doctor. Drug injury lawyers can help those harmed by bad drugs.

The U.S. Food and Drug Administration is responsible for vetting clinical studies performed by drug companies on their products before they are approved. But sometimes those studies are inadequate, resulting in dangerous drugs being sold to consumers. 

Patients who were harmed by these dangerous drugs have turned to the lawyers and attorneys at Schmidt National Law Group for over three decades to help then get compensation for their pain and suffering. We have settled thousands of cases for our clients resulting in cash settlements and payouts. 

Our drug injury lawyers are currently involved in litigation against some of the country’s biggest pharmaceutical companies, including:

Dangerous Drugs News & Litigation

November 20, 2019
Truvada HIV Drug Lawsuit

Federal Government Sues Gilead Over PrEP Patents

Government says taxpayers own HIV prevention drugs The federal government sued Gilead Sciences earlier this month, claiming the drug company infringed on government patents on the […]
November 12, 2019
zantac cancer risk

Zantac Recalled Amid Cancer Concerns

Despite reassurance from FDA, Zantac recalls continue to mount Recalls of prescription and over-the-counter ranitidine, the active ingredient in the heartburn medication Zantac, over potential cancer […]
October 28, 2019

Zantac Recalled Over Cancer Risk

Lawsuits are being filed by people who took prescription and over-the-counter Zantac to treat their heartburn and later developed cancer. If you took Zantac and developed stomach, bladder, or other cancers, you may be entitled to financial compensation.
October 7, 2019
FDA approves descovy for prep

Descovy for PrEP Enters Market

FDA Approves Gilead’s Descovy for HIV Prevention in Men and Transgender Women Only Gilead Sciences Inc. just won approval for a second drug used for HIV […]
September 17, 2019
breast cancer drug lung inflammation

FDA Issues Warning About Ibrance, Kisqali, Verzenio

Breast Cancer Drugs Linked to Severe Lung Inflammation The U.S. Food and Drug Administration (FDA) is warning breast cancer patients about a rare but serious side […]